Skip to main content

Table 1 IDH1 mutation and MGMT promoter methylation status of GBM cell lines and primary cells

From: Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Cells

IDH1

MGMT promoter

U251-MG

Wild-type

Methylated

U373-MG

Wild-type

Methylated

U87-MG

Wild-type

Methylated

Primary culture

Wild-type

Methylated